March 8 Noontime forum to Cover Harm Reduction Approaches to Reducing Drug Use

March 3, 2022

The MMA’s next noon-time forum, which will discuss harm reduction approaches to reducing drug use, takes place March 8 from noon to 1 p.m.   

The forum will include the following experts: 

  • Heather Bell, MD, FASAM, FAAFP, Addiction Services and Primary Care, CentraCare 

  • Ryan Kelly, MD, MS, Internal Medicine, Pediatrics, Harm Reduction Addiction, Community-University Health Care Center at the University of Minnesota, SouthSide Harm Reduction 

  • Sheila P. Vakharia PhD LMSW, Deputy Director, Department of Research and Academic Engagement, Drug Policy Alliance 

Learning objectives for the forum include:  

  • Explore harm reduction approaches to reducing drug use.  

  • Describe the harm reduction approaches currently being used in Minnesota.  

  • Identify policies needed to lessen the personal and public health impacts of behavior associated with alcohol and other substance use. 

To register, click here.  

The forum is free to members, $15 for non-members. This forum is being sponsored by AstraZeneca and COPIC. 

Latest News

Physician/Olympian to Give Inspirational Address at Empowering Physicians Event

August 20, 2026

A physician and Olympian will give an inspirational address as part of this year's Empowering Physicians event on Friday, September 25, at the Minneapolis Institute of Art.

Minnesota Vaccination Rates Trending in Wrong Direction

August 20, 2026

Minnesota received some disturbing news this week from the Centers for Disease Control and Prevention (CDC), as data shows that for the 2025-2026 school year, vaccination rates decreased and non-medical exemptions increased.  

Appellate Court Sides with Texas Medical Association in No Suprises Act Lawsuit

August 20, 2026

On August 11, a federal appellate court sided with the Texas Medical Association (TMA) argument that the way the No Surprises Act’s qualifying payment amount (QPA) is calculated has historically favored payers in arbitration.